Introduction
Assisted ventilation is an established and a successful treatment for hypercapnic ventilatory failure, especially in Duchenne muscular dystrophy (DMD). 1, 2 In 1984, we introduced assisted ventilation as soon as alveolar hypoventilation was identified, even when hypoventilation was confined to sleep only. 3 The justification for early intervention has recently been demonstrated. 4 In end-stage DMD patients, as increasing ventilatory dependency develops, mechanical ventilation needs to be progressively extended into the daytime. 5 At this point, tracheostomy (TR) could be considered. 6 Nevertheless, since 1996, we have initiated noninvasive ventilation (NIV) for daytime use in the DMD patients who develop diurnal hypercapnia in spite of effective nocturnal NIV by nasal mask. 7 Initially, we considered that TR would simply be deferred until the time when NIV would be deemed ineffective for permanent use. With experience, however, we learned that NIV provides safety, effectiveness, and reliability for 24-hour use. 7 In addition, we noticed that most of the DMD patients receiving NIV for 24/24 hours had a clinical course similar to those of patients ventilated via TR. However, evidence-based conclusions should not be inferred from these observations. We, therefore, hypothesized that DMD patients receiving fulltime mechanical ventilation had comparable outcome, irrespective of the interface used. Nevertheless, we believed that it was not ethical to consider a randomized study between noninvasive and invasive ventilation 8 because informed patients and families prefer noninvasive technologies first. Fortuitously, we have used a standard follow-up protocol to DMD patients referred to our center from January 2002 until December 2006: ventilators, techniques of assessment, techniques of respiratory physiotherapy, drug protocol, and hospital caregivers were standardized. Subsequently, we conducted an observational cohort study during this 5-year period. Table 1 shows the data from these patients at inclusion in the study.
Methods

Patients
All the TR patients were ventilated with a cuffless tube, using a speaking valve (Passy-Muir ® , Irvine, California) in line with the ventilator circuit. 9 NIV patients were ventilated during sleep with a nasal mask, commercial (n = 13) or custom made (n = 13), 10 and during the daytime, via a mouthpiece (Mouthpiece angled; Respironics, Murrysville, Pennsylvania). 7 Patients changed the ventilation interface from TR to noninvasive or vice versa, if they wished to. At each visit, the daily duration of ventilation was adapted, if required, to obtain normal blood gases over 24 hours. All 42 patients were equipped with a second ventilator, an intrapulmonary percussion device (Percussionaire ® , Sandpoint, Idaho), 11 and a resuscitation bag. In addition, wheelchair was adapted with a shelf supporting the ventilator and with supplementary batteries to provide 12-V electric supply to the ventilator during the daytime.
The patient's home was adapted for wheelchairbound handicapped people. In addition, people living near the patient were trained by our team not only for usual care such as management of the ventilation system, tracheal suction, and positioning of the interface but also for coping with emergency conditions such as ventilator failure, the procedure for calling medical or technical support, and training to use the resuscitation bag.
Ventilators were regularly checked by members of our Centre for Home Mechanical Ventilation. Patients were offered a regular follow-up at least every 12 months. Mechanical ventilation using volume ventilators, tracheal suction via Cough Assist ® (J.H. Emerson Co., Cambridge, Massachusetts) in NIV patients 12, 13 and via vacuum pump or Cough Assist ® in TR patients, intrapulmonary percussive ventilation every day 11 , and other adequate mechanically assisted cough techniques were available. 14 
Measurements
Respiratory function was recorded: blood gases were observed noninvasively during sleep and wakefulness using transcutaneous technique (TCM3 ® ; Radiometer Medical, Brönshöj (Copenhague, Denmark) and morning venous blood sample. The best of three VC and peak expiratory flows (PEF) were recorded by portable monitor (5410 Ohmeda; DRE Inc, Louisville, Kentucky). Pimax and Pemax were measured at the mouth at functional residual capacity (Micro RPM ® ; Micro Medical Limited, Rochester, Kent, England). Cardiac function was assessed by measurement of the left ventricular ejection fraction (LVEF) and right ventricular ejection fraction (RVEF) with radionuclide ventriculography (*Tc99). An additional Holter electrocardiogram (ECG) monitoring was performed over 24 hours. The social situation was carefully assessed through contact with families and home caregivers, with analysis of the technical and financial resources and with a visit to the home.
Mortality was recorded as follows: causes of death such as low output syndrome (LOS) with LVEF <25% despite adequate treatment, 15 acute respiratory failure with evidence of chest infection confirmed on X-ray and elevated C-reactive protein (CRP), congestive heart failure (CHF) without signs of lung infection, sudden death (SUD) of any origin, accident (ACC), or other causes (OC).
Morbidity was assessed by the occurrence of some predictable complications. Severe complication included the development of tracheal injury (i.e., granuloma and bleeding) requiring adequate treatment (laser, corticosteroids). Mild complications were chronic mucus hypersecretion for more than 2 months without underlying infection, frequent chest infections assessed by positive chest X-ray and elevated CRP, swallowing problems with evidence of lung aspiration observed by systematic postprandial coughing, loss of weight (weight decline >10% within 12 months), need of intragastric feeding (nasogastric or gastrostomy), low LVEF at rest (<50%) despite treatment (angiotensin I converting enzyme (ACE) inhibitors, β-blockers, and spironolactone), and cardiac arrhythmia requiring treatment (amiodarone, 
Results
During the study period, no ventilator failure was recorded and no patients switched from one interface to another. As shown in Table 1 , there was no significant difference between tracheostomized (TR) and noninvasive (NIV) patients except for higher age and PEF at inclusion in TR patients. Table 2 describes the respiratory characteristics of the 18 patients (8 TR vs 10 NIV) who died during the study: age at death, VC, Pimax and Pemax, LVEF, and RVEF were similar. PEF, however, was better preserved in the NIV group.
Causes of death are reported in Table 3 . Two patients died by ACC: one NIV patient living alone died from a domestic ACC (loss of the mouthpiece during a mechanical crash of his wheelchair) and a TR patient died during an endoscopy in an acute hospital, probably by lack of specific medical knowledge of the illness. Four patients died from SUD, without anatomic diagnosis: one TR patient died suddenly in our hospital during the meal, possibly from acute arrhythmia; two NIV patients died at home from a possible pulmonary embolism; one NIV patient died suddenly at home without reported diagnosis, in a very complicated family context. Five patients (three TR vs two NIV) died from radiologically proven lower respiratory tract infection and high CRP, despite treatment with fluids, antibiotics, oxygen, and adequate physiotherapy. Three patients (one TR vs two NIV) died in the emergency room of CHF without clinical radiological or biological evidence of acute chest infection. Finally, four patients (2 TR vs 2 NIV) died from an LOS, as an evolution of their preexisting cardiomyopathy (LVEF < 25%). There was no difference in the causes of death by ventilation interface between the groups. Figure 1 shows the morbidity by interface. Higher rates of tracheal injuries, mucus Accident  2  11  1  13  1  10  Sudden death  4  22  1  13  3  30  Acute respiratory failure  5  28  3  38  2  20  Chronic heart failure  3  17  1  13  2  20  Low input syndrome  4  22  2  25  2 Loss of ambulation; duration of continuous assisted ventilation before inclusion; VC = vital capacity; PEF = peak expiratory flow; Pimax and Pemax = maximal inspiratory and expiratory muscle strength; *P <0.05 (T test).
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hypersecretion, and lung infections were seen in the TR patients. By contrast, loss of weight and the resulting need for enteral feeding were slightly more frequent in the NIV patients. Cardiac dysfunction was similar in the two groups. The home circumstances are reported in Figure 2 . After initiation of continuous ventilation, many patients (7 TR and 18 NIV) lived at home with family or partner. But living at home was not possible for 17 patients (nine TR vs eight NIV): seven patients (one TR vs six NIV) lived in a foster or nursing home where they benefited from privacy and specialized care, three patients (two TR vs one NIV) lived alternatively in our hospital and at home for periods of several weeks, and seven patients (six TR vs one NIV) remained in our rehabilitation hospital with short home discharge during weekends and holidays. Compared with the patients with noninvasive ventilation, tracheostomized patients live preferentially in rehabilitation hospital (with eventual rotation with home) than at home or in nursing home. This position implies financial consequences, which warrant future investigation.
Discussion
We have shown that the use of TR results in some complications that are avoided by the use of noninvasive (NIV) interfaces of ventilation. Among TR patients, 63% had severe complications, and 19%-38% of the patients had mild complications. Living at home and at nursing homes was easier for patients using noninvasive interfaces, while tracheostomized patients spent more time in hospital. Surprisingly, the ages and causes of death were similar in TR and NIV patients.
Causes of death
There is no doubt that a program for assisted ventilation prolongs life in DMD. 16 The most important reason is the dramatically decreasing number of deaths due to chronic respiratory insufficiency, which represented more than 50% of the mortality encountered in the 1980s without mechanical ventilation. 17 When ventilation is used, causes of death are reported to be related to dystrophic changes of respiratory and cardiac muscles. 18 Cardiac-related pathology has become a major cause of death in patients with DMD who receive mechanical ventilation. 16 Left ventricular dysfunction (LVEF) is a more accurate predictor of mortality than ECG. 19 Mechanical ventilation via TR is sometimes presented as a possible beneficial modifier of cardiovascular function. 8, 20 In the current study, we were not able to find any difference in the rate of death for cardiac reasons according to the ventilation mode.
Our data are consistent with a previous finding that mortality in patients with chronic respiratory insufficiency is independent of the choice of either the TR or the noninvasive interface. 21 All our deceased patients belonged to a homogenous group as assessed by the parameters measured in this study. The only exception is PEF that appeared higher in the noninvasive group. A possible explanation is that flow measurements are very sensitive to leakage around the interface, which is indeed difficult to avoid during measurements via the TR.
Complications
Tracheostomized patients
Specific complications associated with the TR are well documented. 22 Most of the complications probably relate more to the use of the cuff rather than to the canula itself. 23 This matter, however, remains controversial. 24 It was suggested that appropriate and skilled care may improve the longevity and the quality of life of neuromuscular patients with TR. 25 All TR patients of the present study were ventilated via an uncuffed tube and used a speaking valve. 9 During the study, no patients developed tracheomalacia or tracheal stenosis. However, we recorded severe complications in more than 60% of TR patients. Tracheal injuries, especially granulomata, required a specific treatment: in most patients, we first treated with corticosteroids to minimize edema. If this was not sufficient, we adapted the canula. In two cases, laser therapy was required. Tracheal injury is the predictable consequence of repeated micro-traumatisms on the mucous membrane by deleterious contact from the latter with the canula or/and with the suction catheter. Despite repeated coaching, it was impossible to guarantee that the tracheal suction was always correctly performed at home or even in our hospital. Undoubtedly, more widespread use of noninvasive coughassistance devices in TR patients should avoid this problem in the future. 26 As expected, no patient with noninvasive ventilation presented with tracheal injury.
Chronic mucus hypersecretion and chest infection
Chronic mucus hypersecretion and chest infection were frequent in TR patients. We assume that mucus hypersecretion is a social handicap due to recurrent suctions in public areas, continuous coughing, and insufficient voice for talking. Although patients are using uncuffed tubes and speaking valves, 27 sub-clinical aspirations are possible leading to mucus retention and infection in a vicious circle with multiple atelectasis. 13 The best therapeutic response is to undergo adequate physiotherapy with intrapulmonary percussion and tracheal suction by skilled caregivers.
Swallowing and feeding problems
Although the occurrence of lung aspiration did not differ between patients, feeding problems appeared more frequently in NIV patients and significant loss of weight required enteral feeding (Figure 1 ). Enteral feeding may be directly related to the noninvasive techniques. As the disease develops with decreasing free ventilator time, some patients need more time for swallowing. Because it is impossible to take air from the mouthpiece when food is still present in the throat, patients progressively adapt their strategy. In a first step, they use their ventilator to achieve air stacking 28 : increased inspiratory air allows a longer period of apnea without dyspnea, providing a longer time for swallowing. However, at a later stage of disease progression, DMD patients will reduce the quantity of food. In this situation, TR may be the wrong option resulting in increased dysphagia. A better solution should be to offer a percutaneous endoscopic gastrostomy (PEG), which may be performed by means of local anesthesia supported by elective NIV 29 even at the patient's bedside. 30 Unfortunately, one NIV patient presented with chronic hypersalivation and dysphagia that was not improved after gastrostomy and specific medication (e.g., atropinics or acid reflux medication H2, proton pump inhibitors (PPI)).
Home circumstances
Unfortunately, we could not use the specific tools for measuring life satisfaction that were reported by some authors either in noninvasive 31, 32 or in tracheal ventilated patients. 33 Experiencing an adequate home life is an important part of quality of life. In this study, the social conditions of the ventilated patients with end-stage Duchenne dystrophy were different according to the interface of ventilation, and there were significant consequences for the patients and their family. When they had the choice, patients preferred to live at home with their family or partner. Home is considered the best, safest, most comfortable, and the least expensive living place for both patients and community. However, when living at home was no longer possible for whatever reason, we observed a clear difference between TR and NIV patients. Compared with TR patients, it was easier for NIV patients to find places in foster and nursing homes, whereas most of TR patients remained in the hospital. The latter is, however, less well adapted and much more expensive than a nursing home. In addition, our data suggest that TR prevents patients from social integration. This is consistent with previous studies reporting data on patients with respiratory failure with other illnesses, 34 on the elderly population, 35 and on children. 36 We assume that TR offers less possibilities to live at home than NIV technology, which contradicts the wishes of all the patients who prefer living at home.
Limitations of the study
In our country, as in all countries around the world, patients and families prefer noninvasive techniques for ventilation during sleep. Because we offered noninvasive interface via a mouthpiece for daytime use, this technique has been immediately accepted by our patient population as the first choice of interface. As previously assumed by others, 8 no prospective randomized study appeared to be ethical. We decided to examine the mortality and morbidity during a welldefined period in which the survey and the therapeutic program were standardized for all the patients referred to our center. We are fully aware of the limits of a nonrandomized comparative cohort study. In addition, the difference in the age at admission and in the time spent with daytime ventilation before inclusion represents a possible limit of this study. Nevertheless, our data suggest clear trends that may be useful to guide clinicians in the choice of an adequate interface of ventilation.
Conclusions
In end-stage Duchenne patients, diurnal ventilation using a noninvasive interface results in similar mortality and causes of death as ventilation via TR. Severe complications associated with the presence of a TR affect 60% of tracheostomized patients, whereas noninvasive interfaces are preferentially associated with dysphagia and the need for enteral feeding. Social integration appears worse when the TR is present. As noninvasive techniques avoid severe complications of the TR with comparable mortality, the authors suggest that noninvasive mouthpiece ventilation should be proposed as default interface when nocturnal mechanical ventilation is extended into the daytime.
